Doxycycline for Clinical Management of Filarial Lymphedema (Mali)

Research question

Determine whether doxycycline treatment daily for 6 weeks improves clinical outcomes (swelling, acute attacks) in lymphedema patients.

Study sites

Notes

This trial is associated with Doxycycline for Clinical Management of Filarial Lymphedema (Sri Lanka) and Doxycycline for Clinical Management of Filarial Lymphedema (India).

The National Clinical Trials registry number for this project is NCT02927496.

This study is Completed

Contact

Eric Ottesen

Funding partner(s)

Reference information

NTD-SC #
56.3
Completed on

Tags

Disease(s)
Lymphatic filariasis
Research topic(s)
Elimination as a public health problem
Morbidity management
Treatment
Study design(s)
Clinical trial
Indicator(s)
Improved Clinical Status